Paul Declerck

KU Leuven

Belgium

Research Interests

Explore related searches

Professors in Belgium

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (10)

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Collaborators (7)

Paul Fisher

UNITED STATES

View details

Geir Åge Løset

Oslo University Hospital

NORWAY

View details

Maarten Dewilde

Professor

KU Leuven

BELGIUM

View details

Marie-Christine BOUTON

INSERM U1148

FRANCE

View details

Véronique Arocas

INSERM U1148

FRANCE

View details

Debby Thomas

Katholieke Universiteit Leuven

BELGIUM

View details

Sandip Kanse

Professor of Biochemistry

University of Oslo

NORWAY

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Paul Declerck

Research Interests

Explore related searches

Contact this professor

Articles (10)

Exploring the Fate of Antibody-Encoding pDNA after Intramuscular Electroporation in Mice

Anti-tau intrabodies: From anti-tau immunoglobulins to the development of functional scFv intrabodies

FLUIDOT: A Modular Microfluidic Platform for Single‐Cell Study and Retrieval, with Applications in Drug Tolerance Screening and Antibody Mining

Higher Drug Exposure During the First 24 Weeks of Ustekinumab Treatment Is Associated With Endoscopic Remission in Crohn’s Disease

Evaluation of serum cytokines and acute phase proteins as possible pharmacodynamic biomarkers to monitor endoscopic remission during ustekinumab therapy in patients with Crohn’s disease

Novel ELISA for the specific detection of protease NEXIN‐1 in human biological samples

Clinically relevant dosing and pharmacokinetics of DNA-encoded antibody therapeutics in a sheep model

Identification of a Phage Display-Derived Peptide Interacting with the N-Terminal Region of Factor VII Activating Protease (FSAP) Enables Characterization of Zymogen Activation

Biosimilar Use and Switching in Belgium: Avenues for Integrated Policymaking.

Intratumoral DNA-based delivery of checkpoint-inhibiting antibodies and interleukin 12 triggers T cell infiltration and anti-tumor response

Collaborators (7)

Paul Fisher

Geir Åge Løset

Maarten Dewilde

Marie-Christine BOUTON

Véronique Arocas

Debby Thomas

Sandip Kanse

Make your next move.